Health
Tiny antibody component shows high potency in SARS-CoV-2 animal models – News-Medical.Net
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug–known as Ab8–for potential use as a therapeutic and prophylactic against SARS-CoV-2.
The researchers report today in the journal…
-
General19 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General19 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General19 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoBrisbane rising on global rankings, but still behind southern capitals